Antidiabetic Drugs - PowerPoint PPT Presentation


PPT – Antidiabetic Drugs PowerPoint presentation | free to download - id: 3b84f1-YjRkO


The Adobe Flash plugin is needed to view this content

Get the plugin now

View by Category
About This Presentation

Antidiabetic Drugs


Lecture 14 Chapter 46 Antidiabetic Drugs Antidiabetic Drugs Drugs used to control diabetes mellitus - a chronic disease that affects carbohydrate metabolism 2 groups ... – PowerPoint PPT presentation

Number of Views:5456
Avg rating:3.0/5.0
Slides: 33
Provided by: harpercol


Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Antidiabetic Drugs

Lecture 14
  • Chapter 46
  • Antidiabetic Drugs

Antidiabetic Drugs
  • Drugs used to control diabetes mellitus - a
    chronic disease that affects carbohydrate
  • 2 groups of antidiabetic agents Insulin oral
    hypoglycemic agents
  • - Oral hypoglycemic agents synthetic
    preparations that stimulate insulin release or
    alter metabolic response to hyperglycemia
  • - Insulin a protein secreted from the beta
    cells of the pancreas - necessary for carbo
    metabolism an important role in protein fat

Antidiabetic Agents
  • Diabetes Mellitus - A chronic disease resulting
    from deficient glucose metabolism, caused by
    insufficient insulin secretion from the beta
    cells high blood sugar (hyperglycemia). 3
  • 1. Polyuria - inc. urine output
  • 2. Polydipsia - inc. thirst
  • 3. Polyphagia - inc. hunger
  • 2 forms of diabetes
  • 1. Insulin-dependent diabetes mellitus (IDDM)
    or type I - was refereed to as juvenile-onset w/
    no insulin secretion

Antidiabetic Agents
  • 2. Non-insulin-dependent diabetes mellitus
    (NIDDM) or type II - was referred to as
    maturity-onset or adult-onset diabetes w/ some
    insulin secretion
  • Unknown how lack of insulin causes diabetes -
    poss. infection, heredity
  • Insulin - Released from the beta cells of the
    islets of Langerhans in the pancreas in response
    to an increase in bld. glucose
  • - Promotes the uptake of glucose, amino acids,
    fatty acids converts them to substances
    stored in body cells

Antidiabetic Agents
  • - Glucose is converted to glycogen for future
    glucose needs in the liver muscle lowers bld.
    glucose level (range for bld. glucose is 70 - 110
  • bld. glucose gt 180 sugar in urine
    diuretic effects polyuria
  • - Insulin can be animal (pork or beef), or
    human (using DNA technology)
  • - Concentration of insulin is 100 U/ml,
    insulin packaged in a 10 ml vial. For accurate
    dosing, insulin can be given in insulin syringes

Antidiabetic Agents
  • - Before using insulin, need to ensure well
    mixed - always roll between hands - Do NOT Shake
    Vial bubbles inaccurate dose
  • - insulin CANNOT be administered orally - GI
    tract secretions destroy insulin structure
  • - Given subcutaneous at a 45 to 90 degree
  • - Regular insulin ONLY can be given IV
  • - Insulin sites need to be rotated to prevent
    lipodystrophy (tissue atrophy or hypertrophy)
    interferes w/ insulin absorption

Antidiabetic Agents Insulin
  • Types of Insulin's - 3 standard types
  • 1. Rapid-acting - Regular insulin - clear soln
    w/o added substances to prolong insulin action
  • Onset 1/2 to 1 h Peak 2 to 4 h Duration
    6 to 8 h
  • 2. Intermediate-acting - NPH, Lente - contain
    protamine (a protein that prolongs the action of
    the insulin)
  • Onset 1 to 2 h Peak 6 to 12 h Duration
    18 to 24 h
  • 3. Long-Acting - Ultralente - contain lg.
    crystals which dissolve slowly to prolong
  • Onset 4 to 8 h, Peak 14 to 20 h Duration
    24 to 36 h

Antidiabetic Agents Insulin
  • Lispro Insulin (Humalog) - a new rapid acting
    insulin approved in 1996
  • Action 5 min. Duration 2 to 4 h - can be
    administered 5 min. before meal time
  • Combination Insulin's - commercially premixed
  • Humulin 70/30, Novolin 70/30, Humulin 50/50
  • (70/30 70 NPH and 30 Reg)
  • Reg can be mixed w/ NPH or Lente - Reg goes in
    first in the syringe Clear to Cloudy

Antidiabetic Agents Insulin
  • SE adverse RXNS
  • -Hypoglycemic - when more insulin is
    administered than needed for glucose metabolism
  • - S S nervous, trembling, uncoordinated,
    cold clammy, incoherent (drunk)
  • - Rx giving sugar orally or IV
  • - Ketoacidosis - An inadequate amt. of insulin
    inability to metabolize sugar fat catabolism
    use of fatty acids (ketones) for energy
  • - S S Extreme thirst, polyria, fruity
    breath odor
  • - Rx Insulin

Antidiabetic Agents Oral Agents
  • Used by persons w/ NIDDM - should NOT be used by
    persons w/ IDDM
  • NIDDM has some degree of insulin secretion by
  • Several classes of oral hypoglycemic agents
  • Sulfonylureas - First Second generation
  • - Chemically related to sulfonamides, but lack
    antibacterial activity - stimulate the beta cells
    to secrete more insulin
  • - 1st generation divided into short,
    intermediate long acting antidiabetics

Antidiabetic Agents Oral Agents
  • - tolbutamide (Orinase) - short Tolazamide
    (Tolinase) - intermediate Chlorpropamide
    (Diabinese) - long
  • - Action - Stimulate beta cells to secrete
  • - Use NIDDM
  • - SE - similar to insulin - hypoglycemic rxn
    w/o adequate food intake
  • - DI - ASA, anticoagulant, anticonvulsants,
    sulfonamides, some NSAIDs can inc. action of
    sulfonylureas an insulin rxn

Antidiabetic Agents Oral Agents
  • Nonsulfonylurease Newer drugs
  • Biguanides Metformin (Glucophage)
  • - Decreases hepatic production of glucose from
    stored glycogen diminishes the inc. in serum
    glucose after a meal
  • - Dec. the absorption of glucose from the
    small intestine
  • - Evidence it inc. insulin receptor
  • - Does not produce hypo or hyperglycemia
  • - SE - N V, anorexia, abd cramping, gas
  • - Can be combined w/ a sulfonylurea insulin

Antidiabetic Agents Oral Agents
  • Alpha-Glucosidase Inhibitor Acarbose (Precose)
  • - Action - inhibits the digestive enzyme in
    sm. intestine responsible for release of glucose
    from the complex carbohydrates (CHO) in the diet
  • - By inhibiting alpha glucosidase (enzyme) -
    the CHO cannot be absorbed they pass into the
    lg. intestine
  • - does not cause a hypoglycemic rxn
  • - Use - for clients who do not achieve results
    on diet alone

Antidiabetic Agents Oral Agents
  • Thiazolidinediones Troglitazone (Rezulin) -
    unrelated to other antidiabetic drugs
  • - Action - Decrease insulin resistance, helps
    muscle cells respond to insulin use glucose
    more effectively
  • - May be used w/ sulfonylurea, metformin, or
  • - May cause serious hepatic toxicity - Not
    used in England
  • Rapaglinide (Prandin) - classification unknown -
  • - For use alone or w/ metfromin - short acting
  • - Action - similar to sulfonylureas, but does
    not cause hypoglycemia

Antidiabetic Agents Oral Agents
  • Hyperglycemic Drugs - Glucagon
  • - Action - A hyperglycemic hormone secreted by
    the alpha cells of the islets of Langerhans -
    Inc. bld sugar by stimulating glycogenolysis
    (breakdown of glycogen to glucose) in the liver -
    protects body cells
  • - Use - Insulin-induced hypoglycemia when
    other methods not available or not working
  • - Clients prone to hypoglycemia should keep in
    home family members taught how to use
  • - Begins to work in 5 to 20 min.

Antidiabetic Agents Oral Agents
  • Diazoxide (Proglycem) - chemically related to
    thiazide diuretics
  • - Action - Inc. bld sugar by inhibiting
    insulin release from the beta cells stimulating
    release of epi (adrenalin from the adrenal
  • - Use - Chronic hypoglycemia caused by
    hyperinsulinism d/t islet cell Ca or hyperplasia
  • - Not used to Rx hypoglycemic rxns
  • - Parenteral form (Hyperstat) used for
    malignant HTN
  • - Oral diazoxide usually does not cause

Chapter 33
  • Anticancer Drugs

Anticancer Drugs
  • In the US, cancer is the 2nd cause of death
    (heart dx - 1st)
  • Results from the alterations in DNA w/in the cell
  • Use of anticancer drugs include - cure, control,
  • Chemo may be used as sole Rx of Ca or in
    conjunction w/ radiation surgery
  • Cell-Cycle Nonspecific Specific - Anticancer
    drugs cause Ca cell death by interfering w/ Ca
    cell replication
  • - Interferes w/ either all phases or a specific
    phase of the cell cycle (pg. 575, fig. VII-I)

Anticancer Drugs
  • - Cell-cycle nonspecific (CCNS) act on any
    phase during the cell cycle
  • - kill the cell during the dividing resting
    phase of cell cycle alkylating drugs, antitumor
    antibiotics, hormones
  • - Cell-cycle specific (CCS) act on a specific
    phase of the cell cycle
  • - effective against rapidly growing Ca cells
    antimetabolites, vica alkaloids, antitumor
  • Growth fraction doubling time are two factors
    that play a major role in the Ca cell response to
    the anticancer drug

Anticancer Drugs
  • - Anticancer drugs are more effective against
    the Ca cells having a high growth fraction -
    leukemias some lymphomas
  • - Ca of the breast colon melanomas low
    growth fraction poor response to
  • - small early forming Ca cells fast-growing
    tumors respond well to anticancer drugs
  • Drug Rx for early dx higher cure rate than late
  • Solid tumors low growth fraction less
    sensitive to drugs

Anticancer Drugs
  • Higher doses of drugs result in better
    tumoricidal (killing) effects
  • Ca growth usually faster in earlier stages. As
    tumor grows bld supply dec growth rate dec.
    drugs more effective against sm. tumors w/
    sufficient bld supply
  • Cancer Chemotherapy - tumor cells are similar to
    normal cells in that it is difficult for antiCa
    drugs to be selective in killing tumor cells
    not normal cells
  • - Drug protocol therapy too long doses too
    high toxic
  • - Eliminating every Ca cell difficult (1
    mill. cells could remain w/o symptoms - ??? on
    continuing Ca therapy

Anticancer Drugs
  • Drug Resistance - tumor resistance can develop
    against an antiCa drug d/t drug used infrequently
    or the tumors location limits the effectiveness
  • - Brain tumors respond poorly (BBB)
  • Combination Chemotherapy - Single-agent drug
    therapy seldom used
  • - Combo of drugs to enhance tumoricidal
  • - CCS CCNS are often combined to max. cell
  • - dec. drug resistance, shorten intensify
    drug effect
  • - inc. destruction of Ca cells, dec. drug
    toxicity - several drugs lower doses less
    injury to normal cells

Anticancer Drugs
  • Alkylating Drugs - one of the largest groups of
    Ca drugs
  • - Kill cells by forming cross-links on DNA
  • - Belong to the CCNS category affect all
    phases of the cell cycle - effective against many
    types of cancers acute chronic leukemias,
    lymphomas, mult. myeloma, solid tumors (breast,
    ovaries, uterus, lungs)
  • - Classified into 4 groups Nitrogen mustards
    (Cyclophosphamide), nitrosoureas (Carmustine),
    alkyl sulfonates (Busulfan), alkylating-like
    drugs (Cisplatin)

Anticancer Drugs
  • Cyclophosphamide (Cytoxan) - Nitrogen mustard
  • - Action - Inhibition of protein synthesis
    through interference w/ DNA replication by
    alkylation of DNA
  • - Use - Hodgkins dx, solid tumors
  • - SE - bone marrow suppression , alopecia, N
    V, diarrhea, wt. loss, hematuria (maintain
    adequate hydration), impotence, sterility
  • - An early antiCa drugs, can be administered PO

Anticancer Drugs
  • Antimetabolites - Oldest group
  • - Resemble natural metabolites - disrupt the
    metabolic processes some of the agents inhibit
    enzyme synthesis
  • - CCS (5-FU, floxuridine - also CCNS)
  • - Subdivided into folic acid (folate)
    antagonists (Methotrexate) - also used as an
    immunosuppressant following organ transplant -
    substitutes for folic acid, needed for the
    synthesis of proteins DNA pyrimidine analogues
    (5-fluorouracil) purine analogues

Anticancer Drugs
  • Flurouracil (Adrucil, 5-FU, Efudex) - IV
  • - Action - CCS, blocks the enzyme action
    necessary for DNA RNA synthesis
  • - low therapeutic index
  • - alone or w/ other drugs, can cross BBB
  • - Use - Ca of breast, cervix, colon, ovary,
    stomach, pancreas
  • - SE - N, V, diarrhea, alopecia, rash, bone
    marrow suppression, stomatitis (inflammation of
    oral mucosa)

Anticancer Drugs
  • Antitumor Antibiotics - (Bleomycin, dactinomycin,
    daunorubicin, doxorubicin) - inhibit protein
    RNA synthesis bind DNA causing fragmentation
  • - Classified as CCNS (except for bleomycin)
  • - Drugs differ from each other are used for
    diff. Cas
  • Doxorubicin (Adriamycin) - IV
  • - Action - Inhibits DNA RNA synthesis
  • - Use - W/ other agents for Ca of breast,
    ovaries, lung, bladder, leukemias, lymphomas
  • - SE - Similar to general adverse rxns to

Anticancer Drugs
  • - Capable of causing vesication - blistering of
    tissue if drug leaks out into surrounding
    interstitial tissue - rxn ranges from painful,
    reddened swelling to deep necrotic lesion needing
    debridement skin grafts
  • - Drug is a deep red color - urine will be red
    1 - 2 days after administration
  • - Can cause cardiotoxicity
  • Mitotic Inhibitors (Vinca Alkaloids) - block cell
    division at M phase of cell cycle (Vincristine,
    Vinblastine, Vinorelbine tartrate) - CCS

Anticancer Drugs
  • - Single drugs or in combo therapy
  • - SE - leukopenia, alopecia, stomatitis, N,V,
  • Hormones Hormone Antagonisits - Used in combo
    therapy for Rx of various Ca.
  • - 2 major actions 1) Agonists that inhibit
    tumor cell growth - estrogen, progestins,
    androgens, adrenocorticosteroids 2) Antagonists
    that compete w/ endogenous hormone -
    aminoglutethimide, tamoxifen
  • Corticosteroids (glucocorticoids) classified as
    antiinflammatory agents - suppressing the
    inflammatory process that occurs w/ tissue

Anticancer Drugs
  • - Hormones also suppress leukicytes is
    effective in controlling leukemia lymphoma
  • - Used w/ other drugs as part of an
    antineoplastic regimen - MOPP (oncovin,
    procarbazine prednisone) - Hodgkins disease
  • - Prednisone frequently prescribed -
    inexpensive cortisone derivative
  • - Dexamethasone hydrocortisone - IM or IV -
    can decrease cerebral edema caused by a brain

Anticancer Drugs
  • Tamoxifen (Nolvadex) -
  • - Action - exact neoplastic action unknown,
    acts as an estrogen antagonist
  • - Use - Breast cancer in women and men
  • - SE - Adverse rxns usually minor well
  • Miscellaneous Agents - antineoplastic drugs whose
    MOA does not place them in a category. Used in
    combo w/ other Ca drugs to Rx a variety of solid
    tumors hematologic malignancies - pactitaxel
    (Taxol), docetaxel (Taxotere), pentostatin
    (Nipent), etoposide (VP-16)

(No Transcript)